Literature DB >> 21188366

Isolation and characterization of the CYP2D6 gene in Felidae with comparison to other mammals.

Tamara Schenekar1, Kathrin A Winkler, Jennifer L Troyer, Steven Weiss.   

Abstract

The highly polymorphic CYP2D6 protein metabolizes about 25% of commonly used drugs and underlies a broad spectrum of drug responses among individuals. In contrast to extensive knowledge on the human CYP2D6 gene, little is known about the gene in non-human mammals. CYP2D6 mRNA from 23 cats (Felidae) spanning seven species were compared to available CYPD6 sequences in ten additional mammals and multiple allelic variants in humans. A relatively high mean dN/dS ratio (0.565) was observed, especially within Felidae. Pairwise dN/dS ratios were non-monotonically distributed with respect to evolutionary distance suggesting either positive selection or retention of slightly deleterious mutations. Positive selection on specific codons, most notably in regions involved in substrate recognition and membrane anchoring is supported and the possible influence of diet on specific amino acid changes in substrate binding sites is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21188366     DOI: 10.1007/s00239-010-9424-1

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  55 in total

Review 1.  Pharmacogenetics of cytochromes P450.

Authors:  J A Hasler
Journal:  Mol Aspects Med       Date:  1999 Feb-Apr

2.  Codon-substitution models for heterogeneous selection pressure at amino acid sites.

Authors:  Z Yang; R Nielsen; N Goldman; A M Pedersen
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

3.  Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level.

Authors:  Jianzhi Zhang; Rasmus Nielsen; Ziheng Yang
Journal:  Mol Biol Evol       Date:  2005-08-17       Impact factor: 16.240

4.  The late Miocene radiation of modern Felidae: a genetic assessment.

Authors:  Warren E Johnson; Eduardo Eizirik; Jill Pecon-Slattery; William J Murphy; Agostinho Antunes; Emma Teeling; Stephen J O'Brien
Journal:  Science       Date:  2006-01-06       Impact factor: 47.728

Review 5.  The rise and fall of deleterious mutation.

Authors:  Kevin J Balbi; Edward J Feil
Journal:  Res Microbiol       Date:  2007-10-02       Impact factor: 3.992

Review 6.  Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping.

Authors:  D Frank; U Jaehde; U Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2007-02-02       Impact factor: 2.953

7.  Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes.

Authors:  M H Court; D J Greenblatt
Journal:  Biochem Pharmacol       Date:  1997-04-04       Impact factor: 5.858

8.  Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences.

Authors:  M H Court; B L Hay-Kraus; D W Hill; A J Kind; D J Greenblatt
Journal:  Drug Metab Dispos       Date:  1999-11       Impact factor: 3.922

9.  Adaptive protein evolution at the Adh locus in Drosophila.

Authors:  J H McDonald; M Kreitman
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

Review 10.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

View more
  1 in total

1.  Bayesian estimation of nonsynonymous/synonymous rate ratios for pairwise sequence comparisons.

Authors:  Konstantinos Angelis; Mario Dos Reis; Ziheng Yang
Journal:  Mol Biol Evol       Date:  2014-04-18       Impact factor: 16.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.